These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8941332)

  • 1. Construction of a chimeric Theiler's murine encephalomyelitis virus containing the leader gene of foot-and-mouth disease virus.
    Piccone ME; Chen HH; Roos RP; Grubman MJ
    Virology; 1996 Dec; 226(1):135-9. PubMed ID: 8941332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.
    Obuchi M; Ohara Y
    Jpn J Infect Dis; 1999 Dec; 52(6):228-33. PubMed ID: 10738359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus.
    Michiels T; Jarousse N; Brahic M
    Virology; 1995 Dec; 214(2):550-8. PubMed ID: 8553557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus.
    Grubman MJ; Zellner M; Bablanian G; Mason PW; Piccone ME
    Virology; 1995 Nov; 213(2):581-9. PubMed ID: 7491782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence.
    Luo M; Toth KS; Zhou L; Pritchard A; Lipton HL
    Virology; 1996 Jun; 220(1):246-50. PubMed ID: 8659122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
    Furler S; Paterna JC; Weibel M; Büeler H
    Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of expression of the aphthovirus protease 3C on viral infection and gene expression.
    Martínez-Salas E; Domingo E
    Virology; 1995 Sep; 212(1):111-20. PubMed ID: 7676620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of mengovirus protein 2A: its function in polyprotein processing and virus reproduction.
    Zoll J; van Kuppeveld FJ; Galama JM; Melchers WJ
    J Gen Virol; 1998 Jan; 79 ( Pt 1)():17-25. PubMed ID: 9460917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication.
    Piccone ME; Rieder E; Mason PW; Grubman MJ
    J Virol; 1995 Sep; 69(9):5376-82. PubMed ID: 7636982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in Escherichia coli and purification of biologically active L proteinase of foot-and-mouth disease virus.
    Piccone ME; Sira S; Zellner M; Grubman MJ
    Virus Res; 1995 Mar; 35(3):263-75. PubMed ID: 7785315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities.
    Medina M; Domingo E; Brangwyn JK; Belsham GJ
    Virology; 1993 May; 194(1):355-9. PubMed ID: 8386879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the foot-and-mouth disease virus 3C protease expressed in Escherichia coli.
    Bablanian GM; Grubman MJ
    Virology; 1993 Nov; 197(1):320-7. PubMed ID: 8212567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of critical amino acids within the foot-and-mouth disease virus leader protein, a cysteine protease.
    Roberts PJ; Belsham GJ
    Virology; 1995 Oct; 213(1):140-6. PubMed ID: 7483257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L* protein of Theiler's murine encephalomyelitis virus is required for virus growth in a murine macrophage-like cell line.
    Obuchi M; Yamamoto J; Odagiri T; Uddin MN; Iizuka H; Ohara Y
    J Virol; 2000 May; 74(10):4898-901. PubMed ID: 10775632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants.
    Gopinath K; Wellink J; Porta C; Taylor KM; Lomonossoff GP; van Kammen A
    Virology; 2000 Feb; 267(2):159-73. PubMed ID: 10662612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UDP-galactose transporter is required for Theiler's virus entry into mammalian cells.
    Hertzler S; Kallio P; Lipton HL
    Virology; 2001 Aug; 286(2):336-44. PubMed ID: 11485401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant equine arteritis virus as an expression vector.
    de Vries AA; Glaser AL; Raamsman MJ; Rottier PJ
    Virology; 2001 Jun; 284(2):259-76. PubMed ID: 11384225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein.
    Chen HH; Kong WP; Roos RP
    J Virol; 1995 Dec; 69(12):8076-8. PubMed ID: 7494325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.
    Jnaoui K; Michiels T
    Virology; 1998 May; 244(2):397-404. PubMed ID: 9601508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.